OneMedNet Corporation (NASDAQ:ONMD – Get Free Report) insider Jeffrey Yu purchased 172,414 shares of the company’s stock in a transaction that occurred on Tuesday, June 16th. The shares were purchased at an average cost of $0.58 per share, with a total value of $100,000.12. Following the completion of the acquisition, the insider owned 8,621,680 shares in the company, valued at $5,000,574.40. The trade was a 2.04% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link.
Jeffrey Yu also recently made the following trade(s):
- On Wednesday, April 1st, Jeffrey Yu purchased 903,614 shares of OneMedNet stock. The shares were purchased at an average cost of $0.83 per share, with a total value of $749,999.62.
OneMedNet Trading Up 20.2%
NASDAQ:ONMD opened at $0.60 on Thursday. The stock has a market cap of $32.78 million, a P/E ratio of -12.05 and a beta of 1.12. The stock has a 50 day simple moving average of $0.85 and a 200 day simple moving average of $0.95. OneMedNet Corporation has a 1-year low of $0.33 and a 1-year high of $4.22.
Hedge Funds Weigh In On OneMedNet
Hedge funds and other institutional investors have recently modified their holdings of the business. HRT Financial LP bought a new position in shares of OneMedNet in the 4th quarter valued at $32,000. Virtu Financial LLC bought a new position in shares of OneMedNet in the 4th quarter valued at $48,000. Jane Street Group LLC bought a new position in shares of OneMedNet in the 4th quarter valued at $119,000. State Street Corp increased its stake in shares of OneMedNet by 41.5% in the 4th quarter. State Street Corp now owns 116,700 shares of the company’s stock valued at $128,000 after purchasing an additional 34,200 shares during the last quarter. Finally, Exencial Wealth Advisors LLC increased its stake in shares of OneMedNet by 1.3% in the 4th quarter. Exencial Wealth Advisors LLC now owns 3,644,861 shares of the company’s stock valued at $4,009,000 after purchasing an additional 45,401 shares during the last quarter. Institutional investors own 0.95% of the company’s stock.
Analyst Upgrades and Downgrades
ONMD has been the subject of several analyst reports. Wall Street Zen cut OneMedNet from a “hold” rating to a “sell” rating in a report on Saturday, May 23rd. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of OneMedNet in a report on Monday, June 1st. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company currently has an average rating of “Sell”.
Check Out Our Latest Research Report on ONMD
OneMedNet Company Profile
OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.
Read More
- Five stocks we like better than OneMedNet
- 2 Quantum Stocks Are Drawing Capital as AI Infrastructure Hits a Wall
- After an Initial Panic, Wall Street’s Leaning Into Apple’s New Siri AI
- Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
- CoreWeave Insider Sales Look Big, But Should Investors Worry?
Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.
